Learn how you can stall the development of full-blown Multiple Myeloma with evidence-based nutritional and supplementation therapies.
Click the orange button to the right to learn more.
Dear Cancer Coach- I am in remission from non-Hodgkin Lymphoma (NHL). I was in near remission after the third chemo treatment of R-CHOP. When first diagnosed with Lymphoma a bone marrow biopsy was performed. There was no Lymphoma in my bone marrow but there evidence of monoclonal gammopathy of undetermined significance ( MGUS.)
After completing the 6 th R-CHOP treatment the MGUS was knocked down to 3 percent and the Lymphoma was gone. Of course the drs advised a wait-and-see course but I feel that I should take some action to prevent it from developing any more than 3 percent. If you can advise I would be so grateful.
Dear NHL Survivor-
Your situation is sort of backwards. In a good way. A person is supposed to be diagnosed with MGUS and then progress to full-blown multiple myeloma or NHL. Your chemotherapy has put your NHL in complete remission. Which is the goal. My interpretation of the presence of MGUS in your blood, however minor, means that, like multiple myeloma and MGUS, the presence of a “blood disorder” is an indicator of the possibility of NHL relapsing.
Oncology recommends a “wait and see” approach to MGUS because it is not cancer, MGUS is a non-malignant, asymptomatic blood disorder. I agree with you however, that all MGUS patients should do what they can to prevent a diagnosis of a full-blown blood cancer (MM or NHL). I know of both MGUS and SMM survivors who have been living with these blood cancer precursors for 15 years or more.
As you can see from the study linked below, curcumin is apoptotic to NHL in the same way that it is apoptotic to MM.
If you are interested I will send you, at no charge, the pre-MM cancer coaching guides that will outline evidence-based, non-toxic, non-conventional therapies that have been shown to be cytotoxic to MM. If you want to learn more about the Pre-MM Cancer Coaching Program, please click the blue button below to watch a FREE webinar that covers the full spectrum of evidence-based therapies for managing MGUS:
“The results showed that curcumin strongly inhibited proliferation of Raji cells, (lymphoma) for Raji cells was 22.8 +/- 1.82 micromol/L and curcumin induced Raji cell apoptosis in a time- and dose-dependent manner…”
“The relative risks of developing multiple myeloma (SIR 34.3), Waldenström’s macroglobulinemia (SIR 63.8), and non-Hodgkin’s lymphoma (SIR 5.9) were significantly increased and independent of time passed from detection of the M-component…”
If you would like the pre-MM cancer coaching guides all I ask is that you keep me abreast of your progress.
Let me know,